Effect of Extended-Release Dexmethylphenidate and Mixed Amphetamine Salts on Sleep: A Double-Blind, Randomized, Crossover Study in Youth with Attention-Deficit Hyperactivity Disorder
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
ObjectiveWe sought to determine the dose-response effects of extended-release (ER) dexmethylphenidate (d-MPH) and ER mixed amphetamine salts (MAS) on objective measures of sleep.MethodsThis was an 8-week, double-blind, placebo-controlled, randomized, two period, crossover study of youth with attention-deficit hyperactivity disorder (ADHD) as confirmed by the Kiddie Schedule for Affective Disorders for School-Age Children–Present and Lifetime version (K-SADS-PL). Children aged 10–17 years were recruited from clinical practice, colleague referrals, and flyers. Participants were randomized to initially receive either d-MPH or MAS. During each 4-week drug period, children received three dose levels (10, 20, and 25/30 mg) in ascending order, with placebo substituted for active medication in a randomized fashion during 1 week of the study. After 4 weeks, participants were switched to the alternative medication for another 4 weeks of treatment. The main outcome measure was sleep duration as measured by actigraphy. Children, parents, and researchers were blinded to drug, dose, and placebo status.ResultsSixty-five participants met the inclusion criteria and were enrolled in the study. Of these, 37 participants with sufficient sleep data for analysis were included. Sleep schedule measures showed a significant effect for dose on sleep start time (F(1,36) = 6.284; p < 0.05), with a significantly later sleep start time when children were receiving 20- or 30-mg doses, compared with placebo (p < 0.05). A significant dose effect was found on actual sleep duration (F(1,36) = 8.112; p < 0.05), with significantly shorter actual sleep duration for subjects receiving 30 mg compared with those receiving placebo (p < 0.05). There were no significant differences on sleep duration or sleep schedule between the two stimulant medications. The trial is complete and closed to follow-up.ConclusionsHigher stimulant doses were associated with reduced sleep duration and later sleep start times, regardless of medication class.Trial registrationClinicalTrials.gov: NCT00393042.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pliszka, S. (2007) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e318054e724 · Cited by 1,765
Cortese, S., Faraone, S. V., Konofal, E., & Lecendreux, M. (2009) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e3181ac09c9 · Cited by 637
JENSEN, P. S., HINSHAW, S. P., SWANSON, J. M., GREENHILL, L. L., CONNERS, C. K., ARNOLD, L. E., ABIKOFF, H. B., ELLIOTT, G., HECHTMAN, L., HOZA, B., et al. (2001) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/00004703-200102000-00008 · Cited by 591 · cited 1×
“Augmentation with behavior therapy for ADHD symptoms may also result in lower stimulant dose, as was found in the National Institute of Mental Health Multimodal Treatment Study [31].”
Arnsten, A. F. T. (2009) · CNS Drugs · doi:10.2165/00023210-200923000-00005 · Cited by 371
Cortese, S., Holtmann, M., Banaschewski, T., Buitelaar, J., Coghill, D., Danckaerts, M., Dittmann, R. W., Graham, J., Taylor, E., Sergeant, J., et al. (2013) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.12036 · Cited by 336 · cited 1×
“The goal of titration is to determine the most effective dose that is well tolerated [16].”
Berk, M., Ng, F., Dodd, S., Callaly, T., Campbell, S., Bernardo, M., & Trauer, T. (2008) · Journal of Evaluation in Clinical Practice · doi:10.1111/j.1365-2753.2007.00921.x · Cited by 280 · cited 1×
“This scale is widely used in clinical trials and has demonstrated clinical utility [29].”
Evidence that sleep deprivation downregulates dopamine D2R in ventral striatum in the human brain
Volkow, N. D., Tomasi, D., Wang, G.-J., Telang, F., Fowler, J. S., Logan, J., Benveniste, H., Kim, R., Thanos, P. K., & Ferré, S. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.0045-12.2012 · Cited by 254 · cited 3×
“Stimulants affect the levels of dopamine (DA) and norepinephrine (NE) by altering the function of the DA transporter (DAT) and NE transporter (NET), inhibiting reuptake of the chemicals at nerve endings and increasing their levels and activity on the postsynaptic neuron [3].”
InfluentialSwanson, J. M., & Volkow, N. D. (2002) · Behavioural Brain Research · doi:10.1016/s0166-4328(01)00433-8 · Cited by 173
Beebe, D. W., Rose, D., & Amin, R. (2010) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2010.03.005 · Cited by 143
Stimulant Rebound: How Common Is It and What Does It Mean?
Carlson, G. A., & Kelly, K. L. (2003) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/104454603322163853 · Cited by 76 · cited 1×
“According to recent literature, there appears to be a rebound effect, but it only significantly affects 10 % of those under stimulant treatment [36].”
Cited by
Townsend, L., Kobak, K., Kearney, C., Milham, M., Andreotti, C., Escalera, J., Alexander, L., Gill, M. K., Birmaher, B., Sylvester, R., et al. (2020) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2019.05.009 · Cited by 265
The role of the circadian system in the etiology and pathophysiology of ADHD: time to redefine ADHD?
Bijlenga, D., Vollebregt, M. A., Kooij, J. J. S., & Arns, M. (2019) · ADHD Attention Deficit and Hyperactivity Disorders · doi:10.1007/s12402-018-0271-z · Cited by 137
Stimulant medications and sleep for youth with ADHD: a meta-analysis
Kidwell, K. M., Van Dyk, T. R., Lundahl, A., & Nelson, T. D. (2015) · Pediatrics · doi:10.1542/peds.2015-1708 · Cited by 133
Sleep disturbances in adolescents with ADHD: A systematic review and framework for future research
Lunsford-Avery, J. R., Krystal, A. D., & Kollins, S. H. (2016) · Clinical Psychology Review · doi:10.1016/j.cpr.2016.10.004 · Cited by 131
“…the studies reviewed in this section utilized standardized subjective or objective (actigraphy) measures of sleep and formally assessed for ADHD diagnosis (during childhood or currently) and most excluded or controlled for demographics and/or comorbidity (Santisteban et al., 2014 is the exception).”
Hyperactivity and male‐specific sleep deficits in the 16p11.2 deletion mouse model of autism
Angelakos, C. C., Watson, A. J., O'Brien, W. T., Krainock, K. S., Nickl‐Jockschat, T., & Abel, T. (2017) · Autism Research · doi:10.1002/aur.1707 · Cited by 83
Metadata
- Authors
- Santisteban, J. A., Stein, M. A., Bergmame, L., & Gruber, R.
- Venue
- CNS Drugs
- Published
- 2014-07-24
- Volume
- 28
- Issue
- 9
- Pages
- 825-833
- ISSN
- 1172-7047 (ISSN-L)
- 1179-1934
- OpenAlex
- W1975745615
- Cited by
- 29
- References
- 12
- FWCI
- 2.69
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effect of Extended-Release Dexmethylphenidate and Mixed Amphetamine Salts on Sleep: A Double-Blind, Randomized, Crossover Study in Youth with Attention-Deficit Hyperactivity Disorder. https://app.cochat.ai/papers/10.1007/s40263-014-0181-3
- The paper
- Santisteban, J. A., Stein, M. A., Bergmame, L., & Gruber, R. (2014). Effect of Extended-Release Dexmethylphenidate and Mixed Amphetamine Salts on Sleep: A Double-Blind, Randomized, Crossover Study in Youth with Attention-Deficit Hyperactivity Disorder. CNS Drugs. https://doi.org/10.1007/s40263-014-0181-3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.